Core Laboratories Inc. (CLB) stock
CLBNYSEOil & Gas Field Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3010% above fair value
$9.01−0.03 (-0.33%)
Close on Nov 12, 2026Market cap $412.87MP/E 26.5Yield 0.44%
Core Laboratories profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Core Laboratories's profit margin for the twelve months ending Sep 30, 2026 was 3.0%. For fiscal 2025 it was 5.6%, against 6.0% the year before. The highest annual figure on record is 7.2% in fiscal 2023.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5.6% | −0.4 |
| FY2024 | Dec 31, 2024 | 6.0% | −1.2 |
| FY2023 | Dec 31, 2023 | 7.2% | +3.2 |
| FY2022 | Dec 31, 2022 | 4.0% | −0.2 |
| FY2021 | Dec 31, 2021 | 4.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 4.1% | −6.5 |
| Q2 FY2026 | Jun 30, 2026 | 4.8% | −3.4 |
| Q1 FY2026 | Mar 31, 2026 | -0.6% | −0.5 |
| Q4 FY2025 | Dec 31, 2025 | 3.6% | −2.1 |
| Q3 FY2025 | Sep 30, 2025 | 10.6% | +1.8 |
| Q2 FY2025 | Jun 30, 2025 | 8.2% | +1.3 |
| Q1 FY2025 | Mar 31, 2025 | -0.1% | −2.6 |
| Q4 FY2024 | Dec 31, 2024 | 5.7% | +4.0 |
| Q3 FY2024 | Sep 30, 2024 | 8.7% | +1.4 |
| Q2 FY2024 | Jun 30, 2024 | 6.9% | −10.9 |
| Q1 FY2024 | Mar 31, 2024 | 2.5% | +0.6 |
| Q4 FY2023 | Dec 31, 2023 | 1.7% | −3.6 |
| Q3 FY2023 | Sep 30, 2023 | 7.4% | +1.4 |
| Q2 FY2023 | Jun 30, 2023 | 17.9% | +12.0 |
| Q1 FY2023 | Mar 31, 2023 | 1.8% | – |
| Q4 FY2022 | Dec 31, 2022 | 5.3% | – |
| Q3 FY2022 | Sep 30, 2022 | 6.0% | – |
| Q2 FY2022 | Jun 30, 2022 | 5.8% | – |
See a number that looks wrong?